| Date | Time | Source | Headline | Symbol | Company |
| 09/18/2024 | 8:00AM | GlobeNewswire Inc. | Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices | NASDAQ:ELUT | Elutia Inc |
| 09/06/2024 | 4:23PM | GlobeNewswire Inc. | Elutia Celebrates First Year | NASDAQ:ELUT | Elutia Inc |
| 09/05/2024 | 4:05PM | GlobeNewswire Inc. | Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators | NASDAQ:ELUT | Elutia Inc |
| 09/03/2024 | 4:05PM | GlobeNewswire Inc. | Elutia to Participate in Upcoming Investor Conferences | NASDAQ:ELUT | Elutia Inc |
| 08/13/2024 | 9:22AM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ELUT | Elutia Inc |
| 08/13/2024 | 9:22AM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ELUT | Elutia Inc |
| 08/07/2024 | 4:05PM | GlobeNewswire Inc. | Elutia Announces Second Quarter 2024 Results | NASDAQ:ELUT | Elutia Inc |
| 08/07/2024 | 4:01PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ELUT | Elutia Inc |
| 08/01/2024 | 4:53PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ELUT | Elutia Inc |
| 08/01/2024 | 4:05PM | GlobeNewswire Inc. | Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds | NASDAQ:ELUT | Elutia Inc |
| 07/31/2024 | 4:05PM | GlobeNewswire Inc. | Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations | NASDAQ:ELUT | Elutia Inc |
| 07/30/2024 | 4:05PM | GlobeNewswire Inc. | Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 | NASDAQ:ELUT | Elutia Inc |
| 07/11/2024 | 4:05PM | GlobeNewswire Inc. | Elutia to Present at the Emerging Growth Conference on Thursday, July 18 | NASDAQ:ELUT | Elutia Inc |
| 06/18/2024 | 4:15PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ELUT | Elutia Inc |
| 06/17/2024 | 8:30AM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:ELUT | Elutia Inc |
| 06/17/2024 | 8:15AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ELUT | Elutia Inc |
| 06/17/2024 | 8:01AM | GlobeNewswire Inc. | Elutia Announces $13.26 Million Registered Direct Offering | NASDAQ:ELUT | Elutia Inc |
| 06/17/2024 | 8:00AM | GlobeNewswire Inc. | Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators | NASDAQ:ELUT | Elutia Inc |
| 06/10/2024 | 5:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ELUT | Elutia Inc |
| 06/10/2024 | 5:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ELUT | Elutia Inc |
| 06/10/2024 | 5:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ELUT | Elutia Inc |
| 06/07/2024 | 5:00PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ELUT | Elutia Inc |
| 05/13/2024 | 5:01PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ELUT | Elutia Inc |
| 05/13/2024 | 8:00AM | GlobeNewswire Inc. | Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024 | NASDAQ:ELUT | Elutia Inc |
| 05/09/2024 | 5:26PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ELUT | Elutia Inc |
| 05/09/2024 | 4:05PM | GlobeNewswire Inc. | Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance | NASDAQ:ELUT | Elutia Inc |
| 05/02/2024 | 4:05PM | GlobeNewswire Inc. | Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 | NASDAQ:ELUT | Elutia Inc |
| 04/24/2024 | 4:05PM | GlobeNewswire Inc. | Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1 | NASDAQ:ELUT | Elutia Inc |
| 03/11/2024 | 9:15AM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:ELUT | Elutia Inc |
| 03/07/2024 | 4:24PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ELUT | Elutia Inc |